{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:13:15Z","timestamp":1790903595804,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR002369"],"award-info":[{"award-number":["UL1TR002369"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020483","name":"Insmed Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.chest.2023.05.036","type":"journal-article","created":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T23:20:59Z","timestamp":1687044059000},"page":"846-859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease"],"prefix":"10.1016","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8249-2632","authenticated-orcid":false,"given":"Sarah A.R.","family":"Siegel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie V.","family":"Philley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Brown-Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4061-5870","authenticated-orcid":false,"given":"Amanda E.","family":"Brunton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8982-0643","authenticated-orcid":false,"given":"Peter E.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8299-0121","authenticated-orcid":false,"given":"Cristina","family":"Fuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Strnad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Richard J.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin L.","family":"Winthrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.chest.2023.05.036_bib1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1513\/AnnalsATS.201804-236OC","article-title":"Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U.S. managed care health plan, 2008-2015","volume":"17","author":"Winthrop","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.chest.2023.05.036_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ccm.2014.10.002","article-title":"Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review","volume":"36","author":"Prevots","year":"2015","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.chest.2023.05.036_bib3","series-title":"Nontuberculous Mycobacterial Disease. Respiratory Medicine","first-page":"163","article-title":"Global epidemiology of NTM disease (except Northern America)","author":"Wagner","year":"2019"},{"issue":"11","key":"10.1016\/j.chest.2023.05.036_bib4","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1099\/ijsem.0.001376","article-title":"Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii and designation of Mycobacteriumabscessus subsp. massiliense comb. nov","volume":"66","author":"Tortoli","year":"2016","journal-title":"Int J Syst Evol Microbiol"},{"issue":"3","key":"10.1016\/j.chest.2023.05.036_bib5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1513\/AnnalsATS.201501-015OI","article-title":"\u201cPleased to meet you, hope you guess my name . . . .\u201d","volume":"12","author":"Griffith","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.chest.2023.05.036_bib6","series-title":"Nontuberculous Mycobacterial Disease. Respiratory Medicine","first-page":"369","article-title":"Disease caused by Mycobacterium abscessus and other rapidly growing mycobacteria (RGM)","author":"Philley","year":"2019"},{"key":"10.1016\/j.chest.2023.05.036_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijid.2016.03.006","article-title":"Update on pulmonary disease due to non-tuberculous mycobacteria","volume":"45","author":"Stout","year":"2016","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.chest.2023.05.036_bib8","doi-asserted-by":"crossref","first-page":"e01523-18","DOI":"10.1128\/AAC.01523-18","article-title":"Genetic correlation of antibiotic susceptibility and resistance genotyping for the Mycobacterium abscessus group","volume":"63","author":"Zheng","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.chest.2023.05.036_bib9","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.01275-08","article-title":"A\u00a0novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae","volume":"53","author":"Nash","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.chest.2023.05.036_bib10","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1128\/AAC.40.7.1676","article-title":"Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus","volume":"40","author":"Wallace","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.chest.2023.05.036_bib11","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1128\/JCM.02950-14","article-title":"Utility of sequencing the erm(41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs","volume":"53","author":"Brown-Elliott","year":"2015","journal-title":"J\u00a0Clin Microbiol"},{"issue":"11","key":"10.1016\/j.chest.2023.05.036_bib12","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1093\/jac\/dks279","article-title":"Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41)","volume":"67","author":"Maurer","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.chest.2023.05.036_bib13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.chest.2021.07.035","article-title":"Treatment of Mycobacterium abscessus pulmonary disease","volume":"161","author":"Griffith","year":"2022","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2023.05.036_bib14","doi-asserted-by":"crossref","first-page":"1801991","DOI":"10.1183\/13993003.01991-2018","article-title":"Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis","volume":"54","author":"Kwak","year":"2019","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2023.05.036_bib15","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciaa241","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.chest.2023.05.036_bib16","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1128\/JCM.01612-13","article-title":"In\u00a0vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates","volume":"51","author":"Brown-Elliott","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"issue":"10","key":"10.1016\/j.chest.2023.05.036_bib17","doi-asserted-by":"crossref","first-page":"e00834","DOI":"10.1128\/JCM.00834-19","article-title":"Antimycobacterial susceptibility testing of nontuberculous mycobacteria","volume":"57","author":"Brown-Elliott","year":"2019","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.chest.2023.05.036_bib18","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/rccm.201604-0700OC","article-title":"Randomized trial of liposomal amikacin\u00a0for inhalation in nontuberculous mycobacterial lung disease","volume":"195","author":"Olivier","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.chest.2023.05.036_bib19","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1164\/rccm.201807-1318OC","article-title":"Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A prospective, open-label, randomized study","volume":"198","author":"Griffith","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2023.05.036_bib20","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3389\/fmicb.2018.00915","article-title":"Amikacin liposome inhalation suspension (ALIS) penetrates non-tuberculous mycobacterial biofilms and enhances amikacin uptake into macrophages","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.chest.2023.05.036_bib21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2023.05.036_bib22","series-title":"Laboratory Detection and Identification of Mycobacteria","year":"2018"},{"key":"10.1016\/j.chest.2023.05.036_bib23","series-title":"Susceptibility Testing of Mycobacteria, Nocardia Spp., and Other Aerobic Actinomycetes","year":"2018"},{"key":"10.1016\/j.chest.2023.05.036_bib24","series-title":"Performance Standards for Susceptibility Testing of Mycobacteria, Nocardia Spp., and Other Aerobic Actinomycetes","year":"2018"},{"issue":"6","key":"10.1016\/j.chest.2023.05.036_bib25","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1086\/515328","article-title":"A\u00a0single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae","volume":"177","author":"Prammananan","year":"1998","journal-title":"J\u00a0Infect Dis"},{"issue":"12","key":"10.1016\/j.chest.2023.05.036_bib26","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1128\/JCM.42.12.5582-5587.2004","article-title":"Pulsed-field gel electrophoresis study of Mycobacterium abscessus isolates previously affected by DNA degradation","volume":"42","author":"Zhang","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.chest.2023.05.036_bib27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1164\/rccm.201003-0395OC","article-title":"Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus","volume":"183","author":"Koh","year":"2011","journal-title":"Am J Respir\u00a0Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2023.05.036_bib30","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijantimicag.2009.12.008","article-title":"High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria","volume":"35","author":"Shen","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.chest.2023.05.036_bib28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.chest.2022.01.015","article-title":"Safety and outcomes of amikacin liposome inhalation suspension for mycobacterium abscessus pulmonary disease: a NTM-NET study","volume":"162","author":"Zweijpfenning","year":"2022","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.chest.2023.05.036_bib29","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1128\/AAC.01505-12","article-title":"In\u00a0vitro synergy between clofazimine\u00a0and amikacin in treatment of nontuberculous mycobacterial disease","volume":"56","author":"van Ingen","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369223008073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369223008073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T01:28:41Z","timestamp":1727486921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369223008073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0012369223008073"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2023.05.036","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2023.05.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}